Alzheimer’s disease is the most common cause of dementia, presenting as a gradual decline in memory, thinking, behaviour and social skills. New tests might be able to diagnose the disease when symptoms are very mild, so that the latest therapeutic advances in the field can be applied. Here, Pathology in Practice Science Editor Brian Nation compiles a small selection of current research interest.
Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Monteiro AR, Barbosa DJ, Remião F, Silva R. Biochem Pharmacol. 2023 May; 211: 115522. doi: 10.1016/j.bcp.2023.115522.
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases that affect millions of people worldwide, with both prevalence and incidence increasing with age. It is characterised by cognitive decline associated, specifically, with degeneration of cholinergic neurons.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
